Journey Medical (DERM) Receivables - Net (2020 - 2025)
Journey Medical's Receivables - Net history spans 6 years, with the latest figure at $29.8 million for Q4 2025.
- For the quarter ending Q4 2025, Receivables - Net rose 191.11% year-over-year to $29.8 million, compared with a TTM value of $29.8 million through Dec 2025, up 191.11%, and an annual FY2025 reading of $29.8 million, up 191.11% over the prior year.
- Receivables - Net for Q4 2025 was $29.8 million at Journey Medical, up from $18.0 million in the prior quarter.
- The five-year high for Receivables - Net was $31.7 million in Q3 2021, with the low at $8.0 million in Q3 2023.
- Average Receivables - Net over 5 years is $20.1 million, with a median of $18.0 million recorded in 2025.
- Year-over-year, Receivables - Net plummeted 72.0% in 2023 and then skyrocketed 191.11% in 2025.
- Tracing DERM's Receivables - Net over 5 years: stood at $23.1 million in 2021, then increased by 22.05% to $28.2 million in 2022, then plummeted by 46.04% to $15.2 million in 2023, then plummeted by 32.79% to $10.2 million in 2024, then skyrocketed by 191.11% to $29.8 million in 2025.
- Per Business Quant, the three most recent readings for DERM's Receivables - Net are $29.8 million (Q4 2025), $18.0 million (Q3 2025), and $15.6 million (Q2 2025).